Home 2019-02-20T12:13:45+00:00


At M4K Pharma, we are using open science to revolutionize how affordable new treatments are discovered and developed. Through our Medicines4Kids program, we will aggregate and align the work of global academics, foundations and industry researchers to advance new cures for childhood diseases not well-served by current business models.

M4K Pharma’s Data:
In line with M4K Pharma’s open science principles, we are committed to sharing our research data freely in the public domain. Our data is currently available for public viewing in the video recordings of our monthly open scientific updates, which are posted to our Blog and also available through our YouTube Channel. Data will be openly available in a downloadable format soon.

Imagine a 🇨🇦 “Genes to Affordable Medicines” initiative to invent first-in-class, affordably-priced medicines. It’s possible using #openscience!
@NRC_CNRC @CIHR_IRSC @GenomeCanada @ISED_CA @HealthCanada @OICR_news @C_D_R_D @IRICoR_ @GenomeQuebec @GenomeBC @ONeconomy @KrembilF

Support @ICR_London! They do awesome science, all for the public good, and have been tremendous collaborators of @M4KPharma and its quest to invent new medicines and price them affordably.


This is real science (and the advantage of open lab notebooks). Negative results and all! https://t.co/KYkLQJBZ0y

Open source pharma to transform how we find drugs? Especially needed for rare diseases w/o a big market. Checkout @M4KPharma Open drug discovery for a rare children’s brain cancer https://t.co/Du7bkNrOpu @aisha1309 #openscience @Telegraph

Nice piece with some great commentary from, @MatToddChem. They did not mention it, but @M4KPharma is for sure a good (only?) example of a pharma actively pursuing a new medicine 100% in the open. https://t.co/zlpiYtOyGO

Load More...

Latest Blog Posts